Cardiac sarcoidosis is a potentially fatal complication of sarcoidosis. The 1993 guidelines of
the Ministry of Health, Labour, and Welfare (MHLW) of Japan have been used as the …

Sarcoidosis is a multi-system inflammatory disorder of unknown etiology resulting in
formation of non-caseating granulomas. Cardiac involvement—which is associated with …

Sarcoidosis is a systemic granulomatous disease of unknown cause. Sarcoidosis involving
the heart, ie, cardiac sarcoidosis, affects the prognosis of patients significantly as it may lead …

Background Sarcoidosis is a systemic disease characterized by significant clinical
heterogeneity. Although most frequently involving the lungs, sarcoidosis may affect any …

Objectives: This study sought to relate imaging findings on positron emission tomography
(PET) to adverse cardiac events in patients referred for evaluation of known or suspected …

Background—Although cardiac magnetic resonance (CMR) and positron emission
tomography (PET) detect different pathological attributes of cardiac sarcoidosis (CS), the …

The classes of recommendations and levels of evidence in these guidelines were
determined and described according to the “Guidelines for the treatment of acute and …

This joint position paper illustrates the role and the correct use of echocardiography,
radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography …

Background Cardiac sarcoidosis (CS) causes substantial morbidity and sudden death. Early
diagnosis and risk stratification are warranted. Methods Ambulatory patients with sarcoidosis …

Cardiac sarcoidosis (CS) is a rare but potentially fatal condition that may present with a wide
range of clinical manifestations including congestive heart failure, conduction abnormalities …